Clinical Trial Update: Fibroscan Study in HCC [NA]

View source ↗

Summary

The document provides an update on a Fibroscan study in hepatocellular carcinoma, including patients scheduled for transarterial chemoembolization or systemic t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Confirmed Diagnosis of Hepatocellular Carcinoma, Patients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy Surgery | NA | Status: ACTIVE_NOT_RECRUITING